Compare WVE & APLE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | WVE | APLE |
|---|---|---|
| Founded | 2012 | 2007 |
| Country | Singapore | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Real Estate Investment Trusts |
| Sector | Health Care | Real Estate |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 3.0B | 2.9B |
| IPO Year | 2015 | 2015 |
| Metric | WVE | APLE |
|---|---|---|
| Price | $13.40 | $12.36 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 16 | 7 |
| Target Price | ★ $29.94 | $14.14 |
| AVG Volume (30 Days) | ★ 4.0M | 1.7M |
| Earning Date | 03-03-2026 | 02-23-2026 |
| Dividend Yield | N/A | ★ 7.71% |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 0.74 |
| Revenue | $109,230,000.00 | ★ $1,418,986,000.00 |
| Revenue This Year | N/A | $0.39 |
| Revenue Next Year | $16.20 | $2.02 |
| P/E Ratio | ★ N/A | $16.94 |
| Revenue Growth | ★ 103.75 | 0.57 |
| 52 Week Low | $5.28 | $10.44 |
| 52 Week High | $21.73 | $16.02 |
| Indicator | WVE | APLE |
|---|---|---|
| Relative Strength Index (RSI) | 43.21 | 55.19 |
| Support Level | $13.22 | $12.14 |
| Resistance Level | $14.51 | $12.70 |
| Average True Range (ATR) | 1.33 | 0.26 |
| MACD | -0.38 | -0.00 |
| Stochastic Oscillator | 3.18 | 59.76 |
WAVE Life Sciences Ltd is a clinical-stage biotechnology company focused on unlocking the broad potential of RNA medicines also known as oligonucleotides, targeting ribonucleic acid (RNA), to transform human health. RNA medicines platform, PRISM, combines multiple modalities, chemistry innovation, and deep insights into human genetics to deliver scientific breakthroughs that treat both rare and prevalent disorders. Its toolkit of RNA-targeting modalities includes RNA editing, antisense silencing, and RNA interference, providing capabilities for designing and sustainably delivering candidates that optimally address disease biology. Its programs are for rare and prevalent diseases, including alpha-1 antitrypsin deficiency, obesity, Duchenne muscular dystrophy, and Huntington's disease.
Apple Hospitality REIT Inc is a real estate investment trust that invests in income-producing real estate, majorly in the lodging sector, in the United States. It chiefly invests in upscale service hotels. All of the company's hotels operate under the Marriott or Hilton brands. Apple Hospitality has wholly-owned taxable REIT subsidiaries, which lease all of the company's hotels from wholly-owned qualified REIT subsidiaries. These hotels are managed under separate agreements with various hotel management companies that are unaffiliated with Apple Hospitality. The company derives its income from hotel revenue, its sole segment.